These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33334303)

  • 21. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
    Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients.
    Fabrizi F; Lunghi G; Andrulli S; Pagliari B; Mangano S; Faranna P; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1997 Jul; 12(7):1394-8. PubMed ID: 9249775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
    Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
    Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus guidelines for the management of hepatitis C infection.
    Consensus Guidelines Committee for the Management of Hepatitis C Infection
    Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression.
    Zechini B; Pasquazzi C; Aceti A
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):891-6. PubMed ID: 15316414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3.
    Ullah A; Rehman IU; Ommer K; Ahmed N; Odenthal M; Yu X; Ahmad J; Nadeem T; Ali Q; Ahmad B
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies.
    Roberts SK; Mitchell J; Leung R; Booth D; Bollipo S; Ostapowicz G; Sloss A; McCaughan GW; Dore GJ; Thompson A; Crawford DH; Sievert W; Weltman M; Cheng W; George J;
    J Gastroenterol Hepatol; 2014 Jan; 29(1):179-84. PubMed ID: 24219707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(3):e0120794. PubMed ID: 25790297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and C patients.
    Helaly GF
    Br J Biomed Sci; 2011; 68(1):38-42. PubMed ID: 21473261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.
    Reedy DW; Loo AT; Levine RA
    Dig Dis Sci; 1998 Sep; 43(9):2156-9. PubMed ID: 9753286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
    Trebicka J; Anadol E; Elfimova N; Strack I; Roggendorf M; Viazov S; Wedemeyer I; Drebber U; Rockstroh J; Sauerbruch T; Dienes HP; Odenthal M
    J Hepatol; 2013 Feb; 58(2):234-9. PubMed ID: 23085648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of ALT and AST levels to the histopathological changes in liver biopsies of patients with chronic hepatitis C genotype 4.
    Khattab H; Fouad A; Hamza M; Mohey MA; El-Akel W; Ghoneim H; Abul-Fotouh A; Esmat G
    Arab J Gastroenterol; 2015 Jun; 16(2):50-3. PubMed ID: 26184441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.
    Butt AM; Raja AJ; Siddique S; Khan JS; Shahid M; Tayyab GU; Minhas Z; Umar M; Idrees M; Tong Y
    Sci Rep; 2016 Feb; 6():21510. PubMed ID: 26898400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of alpha-fetoprotein in chronic hepatitis C.
    Tai WC; Hu TH; Wang JH; Hung CH; Lu SN; Changchien CS; Lee CM
    J Formos Med Assoc; 2009 Mar; 108(3):210-8. PubMed ID: 19293036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3.
    Ullah A; Yu X; Odenthal M; Meemboor S; Ahmad B; Rehman IU; Ahmad J; Ali Q; Nadeem T
    PLoS One; 2022; 17(5):e0268526. PubMed ID: 35617369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrahepatic
    Guedes de Sá KS; Amoras EDSG; Conde SRSDS; Queiroz MAF; Cayres-Vallinoto IMV; Ishak R; Vallinoto ACR
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.